METTL14 and breast cancer: METTL14 was recognized and recruited by elevating LNC942, which in turn increased METTL14-dependent m6A methylation expression levels and its associated mRNA stability and protein expression of downstream targets CXCR4 and CYP1B1 in BC (Sun et al., 2020).